Cargando…
The CRIPSR/Cas gene‐editing system—an immature but useful toolkit for experimental and clinical medicine
A Chinese scientist, Jiankui He, and his creation of the world's first genetically altered baby made headlines recently. As a newly developed gene‐editing technique, the CRISPR/Cas system should not be applied to human beings for reproductive purposes until it has been extensively tested. Howev...
Autores principales: | Yang, Yuyan, Huang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431121/ https://www.ncbi.nlm.nih.gov/pubmed/31016281 http://dx.doi.org/10.1002/ame2.12061 |
Ejemplares similares
-
Somatic Cell Nuclear Transfer Followed by CRIPSR/Cas9 Microinjection Results in Highly Efficient Genome Editing in Cloned Pigs
por: Sheets, Timothy P., et al.
Publicado: (2016) -
SgRNA Expression of CRIPSR-Cas9 System Based on MiRNA Polycistrons as a Versatile Tool to Manipulate Multiple and Tissue-Specific Genome Editing
por: Xie, Chen, et al.
Publicado: (2017) -
Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research
por: Eun, Kiyoung, et al.
Publicado: (2019) -
Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase
por: Tu, Jian, et al.
Publicado: (2018) -
CRISPR-Cas systems: ushering in the new genome editing era
por: Perez Rojo, Fernando, et al.
Publicado: (2018)